
This episode explores GLP-1 medications, their effects on weight loss and metabolic health, and the cultural implications surrounding their use.
In today’s episode of My Verbal Journal , we’re diving into the GLP-1 era : Ozempic, tirzepatide, and the cultural explosion surrounding them. From type 2 diabetes treatment to 20% weight loss trials, these medications have completely changed the obesity conversation. But with that shift has come celebrity/influencer culture, telehealth prescriptions, college girls using it cosmetically, and a lot of misinformation. In this episode, I break down: What GLP-1 medications actually do in the body (brain, gut, pancreas) Why they lead to weight loss The real benefits for metabolic health The overlooked risks: muscle loss, nutrient deficiencies, metabolic adaptation Why strength training and protein are non-negotiable Who is an appropriate candidate and who isn’t The psychological side of shrinking your body Why these drugs are tools, not shortcuts We also talk about the bigger picture: how obesity is now recognized as a chronic disease, how media shaped the “Ozempic trend,” and why the smallest body possible should never be the goal. Personal IG: @macileejones Podcast IG: @myverbaljournal.letschat
Host: Maci Jones
Organizations: telehealth
Products: Ozempic, tirzepatide
Places: college
Explore listener stats, chart rankings, contacts and more on the My Verbal Journal: Let’s Chat podcast page.